DK643389D0 - Endotelcellevaekstfaktor samt fremgangsmaade til oprensning deraf - Google Patents

Endotelcellevaekstfaktor samt fremgangsmaade til oprensning deraf

Info

Publication number
DK643389D0
DK643389D0 DK643389A DK643389A DK643389D0 DK 643389 D0 DK643389 D0 DK 643389D0 DK 643389 A DK643389 A DK 643389A DK 643389 A DK643389 A DK 643389A DK 643389 D0 DK643389 D0 DK 643389D0
Authority
DK
Denmark
Prior art keywords
subjecting
pooling
active fractions
resulting active
growth factor
Prior art date
Application number
DK643389A
Other languages
English (en)
Other versions
DK643389A (da
Inventor
Carl-Henrik Heldin
Kohei Miyazono
Christer Wernstedt
Ulf Hellman
Fumimaro Takaku
Fuyuki Ishikawa
Original Assignee
Res Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Corp Technologies Inc filed Critical Res Corp Technologies Inc
Publication of DK643389D0 publication Critical patent/DK643389D0/da
Publication of DK643389A publication Critical patent/DK643389A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK643389A 1988-12-20 1989-12-18 Endotelcellevaekstfaktor samt fremgangsmaade til oprensning deraf DK643389A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28805688A 1988-12-20 1988-12-20

Publications (2)

Publication Number Publication Date
DK643389D0 true DK643389D0 (da) 1989-12-18
DK643389A DK643389A (da) 1990-06-21

Family

ID=23105561

Family Applications (1)

Application Number Title Priority Date Filing Date
DK643389A DK643389A (da) 1988-12-20 1989-12-18 Endotelcellevaekstfaktor samt fremgangsmaade til oprensning deraf

Country Status (13)

Country Link
EP (2) EP0377855B1 (da)
JP (1) JPH02288897A (da)
KR (1) KR900009989A (da)
AT (1) ATE145242T1 (da)
AU (1) AU4687989A (da)
CA (1) CA2005600A1 (da)
DE (1) DE68927458T2 (da)
DK (1) DK643389A (da)
FI (1) FI896137A7 (da)
IL (1) IL92735A (da)
NO (1) NO895055L (da)
NZ (1) NZ231837A (da)
PT (1) PT92613B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI890342L (fi) * 1988-01-25 1989-07-26 American Cyanamid Co Hjaernmitogener, som binds till heparin.
CA2005600A1 (en) 1988-12-20 1990-06-20 Cal-Henrik Heldin Endothelial cell growth factor
WO1992018153A1 (en) * 1991-04-12 1992-10-29 Creative Biomolecules, Inc. Method of treating gastrointestinal ulcers with platelet derived growth factor
DE4118912C1 (da) * 1991-06-08 1992-07-02 Biotest Pharma Gmbh, 6072 Dreieich, De
GB9121815D0 (en) * 1991-10-15 1991-11-27 Delta Biotechnology Ltd Medicine
JPH08508511A (ja) * 1993-04-29 1996-09-10 ワシントン・ユニバーシテイー 副行循環の改善への血小板由来成長因子の使用
JP3268147B2 (ja) * 1994-12-28 2002-03-25 大鵬薬品工業株式会社 モノクローナル抗体
AU729459B2 (en) * 1996-11-15 2001-02-01 Genentech Inc. Purification of neurotrophins
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
AUPP263498A0 (en) * 1998-03-27 1998-04-23 Walter And Eliza Hall Institute Of Medical Research, The Novel therapeutic molecules and uses therefor
EP2389942B1 (en) * 2010-05-25 2013-01-23 GwoWei Technology Co., Ltd. Virally-inactivated growth factors-containing platelet lysate depleted of PDGF and VEGF and preparation method thereof
CA2823505A1 (en) * 2011-01-26 2012-08-02 Megmilk Snow Brand Co., Ltd. Agent for improving peripheral sensitivity of skin
HK1221402A1 (zh) 2013-04-02 2017-06-02 University Of Florida Research Foundation, Inc. 用於诱导并调节血管生成的组合物和方法以及用於鉴别血管生成调节剂的方法和实验

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2005600A1 (en) 1988-12-20 1990-06-20 Cal-Henrik Heldin Endothelial cell growth factor

Also Published As

Publication number Publication date
EP0377855A3 (en) 1990-12-19
CA2005600A1 (en) 1990-06-20
NO895055L (no) 1990-06-21
EP0377855B1 (en) 1996-11-13
AU4687989A (en) 1990-06-28
KR900009989A (ko) 1990-07-06
PT92613A (pt) 1990-06-29
FI896137A7 (fi) 1990-06-21
EP0377855A2 (en) 1990-07-18
NZ231837A (en) 1992-03-26
FI896137A0 (fi) 1989-12-20
DK643389A (da) 1990-06-21
ATE145242T1 (de) 1996-11-15
EP0685490A1 (en) 1995-12-06
IL92735A (en) 1998-06-15
DE68927458T2 (de) 1997-04-03
PT92613B (pt) 1996-09-30
JPH02288897A (ja) 1990-11-28
NO895055D0 (no) 1989-12-15
IL92735A0 (en) 1990-09-17
DE68927458D1 (de) 1996-12-19

Similar Documents

Publication Publication Date Title
DK643389A (da) Endotelcellevaekstfaktor samt fremgangsmaade til oprensning deraf
DK0447585T4 (da) Fremgangsmåde til fremstilling af et intravenøst tolerant immunglobulin-G-præparat
PT99248A (pt) Processo para a purificcao de anticorpos
EP0212688A3 (en) Substituted and crosslinked glucans, process for preparing them and use thereof
DE3853224D1 (de) Produktion von Proteinen in aktiver Form.
DE3584536D1 (de) Vorrichtung zur steuerkraftstabilisierung bei einem drehfluegelflugzeug.
ES2093031T3 (es) Metodo para purificar el factor de crecimiento transformante (tgf).
SE7909897L (sv) Rening av gammaglobulinderivat
DE3788170D1 (de) Methode zur Reinigung und Isolierung von zwei ionischen Formen von Somatomedin.
ATE39889T1 (de) Vorrichtung zum umdrehen eines gelenkten kraftfahrzeuges.
DK1624057T3 (da) Hyaluronidaseholdigt præparat samt dets farmaceutiske anvendelse
AU551407B2 (en) Crystalline human leukocyte interferon
FI874431A0 (fi) Foerfarande foer rening av antikroppar.
ES8604303A1 (es) Un procedimiento de purificacion de una proteasa de quimopapaina
EP0446850A3 (en) Process for purifying recombinant human beta-interferon
FI840351A0 (fi) Nytt foerfarande foer framstaellning av av klebsiella pneumonia extraherade immunsystemet stimuleraacylglykoproteiner
CA2062729A1 (en) Interferon purification process
FR2680879B1 (fr) Procede de fabrication d'ebauches de ferrules ou de multiferrules, et ebauches obtenues par ce procede.
Rooks Robots finish off for Rockwell.
RO103684A2 (en) PRODUCTION METHOD OF IMMUNO-GLOBULIN A1(IgA1)
IT8409381A0 (it) Dispositivo per sospensioni di motoveicoli a due ruote che consente,oltre al molleggio, l'assetto variabile su due posizioni:posizione alta per la marcia;posizione bassa per il parcheggio
IT8819774A0 (it) Processo per l'assorbimento di ammoniaca in una torbida acida.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment